Figure 4From: Safety and pharmacological characterization of the molecular tweezer CLR01 – a broad-spectrum inhibitor of amyloid proteins’ toxicity CLR01 plasma concentration following different routes of administration. The graph shows levels of CLR01 in plasma by intravenous (black line) or subcutaneous (blue line) injection at 1 mg/kg, or by oral gavage (red line) at 10 mg/kg over 24 h. Data are given as mean ± SD.Back to article page